![Hoi-Yoon Jung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hoi-Yoon Jung
Algemeen Directeur bij NOVMETAPHARMA CO., LTD.
Actieve functies van Hoi-Yoon Jung
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NOVMETAPHARMA CO., LTD. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - | |
Hoofd Techniek/Wetenschap/O&O | - | - | |
NovMetaHealth Co. Ltd.
![]() NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Directeur/Bestuurslid | - | - |
Hoofd Techniek/Wetenschap/O&O | - | - | |
Pohang University of Science & Technology | Corporate Officer/Principal | 01-01-2019 | - |
Loopbaan van Hoi-Yoon Jung
Opleiding van Hoi-Yoon Jung
Handong Global University | Graduate Degree |
Pohang University of Science & Technology | Doctorate Degree |
Statistieken
Internationaal
Zuid-Korea | 5 |
Operationeel
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NOVMETAPHARMA CO., LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
NovMetaHealth Co. Ltd.
![]() NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Beurs
- Insiders
- Hoi-Yoon Jung
- Ervaring